Option Care Health (NASDAQ:OPCH) Updates Q4 Earnings Guidance

Option Care Health (NASDAQ:OPCH) issued an update on its fourth quarter earnings guidance on Monday morning. The company provided earnings per share guidance of $0.42-0.45 for the period, compared to the consensus earnings per share estimate of $0.35. The company issued revenue guidance of $1.34-1.35 billion, compared to the consensus revenue estimate of $1.27 billion. Option Care Health also updated its FY 2024 guidance to 1.550-1.590 EPS.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on OPCH shares. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a research report on Friday. UBS Group assumed coverage on Option Care Health in a research report on Thursday, December 5th. They set a “neutral” rating and a $26.00 price objective for the company. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $26.00 to $33.00 in a research note on Monday. The Goldman Sachs Group cut shares of Option Care Health from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. Finally, Barrington Research cut their price objective on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a report on Thursday, October 31st. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, Option Care Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $29.71.

Option Care Health Stock Up 15.5 %

OPCH opened at $27.72 on Tuesday. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. Option Care Health has a 12 month low of $21.39 and a 12 month high of $34.63. The stock has a market capitalization of $4.72 billion, a P/E ratio of 23.29, a P/E/G ratio of 2.43 and a beta of 1.31. The business has a 50 day simple moving average of $23.20 and a 200-day simple moving average of $27.69.

Insider Buying and Selling

In other news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The stock was purchased at an average price of $22.54 per share, with a total value of $969,220.00. Following the purchase, the director now owns 326,334 shares of the company’s stock, valued at $7,355,568.36. This trade represents a 15.18 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. 0.64% of the stock is currently owned by insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.